Dicerna™ Appoints Rob Ciappenelli Chief Commercial Officer
by
Share this page:
by
Dicerna™ Appoints Rob Ciappenelli Chief Commercial Officer
We use RNA interference, or RNAi, to create medicines that silence the genes that cause or contribute to disease. Our goal is to provide life-changing therapies to people living with rare and common diseases.